Directors of the first three NCI-designated Comprehensive Cancer Centers are learning from the past, starting with the National Cancer Act, and mapping an equitable future for oncology.
The vast majority of hospitals in the United States—up to 80%—treat patient populations that are disproportionately white, U.S. News & World Report said, unveiling a new suite of health equity measures earlier this week.
When Ben Harder and his team of health analysts at U.S. News & World Report developed a suite of health equity measures for America’s hospitals, they expected to find some level of disparity, but nothing prepared them for the shocking magnitude of inequity they uncovered.
To comprehend the significance of disparities articulated in the U.S. News study and define the scorecards’ impact on bragging rights at cancer centers, The Cancer Letter asked four leaders in oncology to evaluate the health equity measures.
As a comprehensive cancer center in Los Angeles, City of Hope serves one of the most diverse—and vulnerable—patient populations in the U.S.
Two academic health systems in Cleveland are creating programs and faculty positions to direct institutional initiatives on health equity—at the executive level.
A recent analysis of the National Cancer Institute’s workforce and grant recipients shows that Black and Hispanic scientists are dramatically underrepresented across key metrics, both intramural and extramural.
Robust and effective mentorship is imperative to building a successful career in academic medicine.
Racial and ethnic minorities that are underrepresented in medicine have even lower representation in leadership of NCI-designated cancer centers, a study by Memorial Sloan Kettering Cancer Center researchers found.
This is the first installment of conversations about diversity, equity, and inclusion in recruitment and mentorship at academic cancer centers.
